Skip to main content

A Study for Management of Ocular Side Effects in Subjects with EGFR-Amplified Glioblastoma receiving Depatuxizumab Mafodotin

Clinical Trial Grant
Duke Scholars

Administered By

Duke Cancer Institute

Awarded By

AbbVie Inc.

Start Date

September 26, 2018

End Date

September 30, 2020
 

Administered By

Duke Cancer Institute

Awarded By

AbbVie Inc.

Start Date

September 26, 2018

End Date

September 30, 2020